Iron deficiency in children with global developmental delay and autism spectrum disorder

2013 ◽  
Vol 50 (5) ◽  
pp. 356-361 ◽  
Author(s):  
Samuel Sidrak ◽  
Terence Yoong ◽  
Susan Woolfenden
Keyword(s):  
Autism Spectrum Disorder ◽  
Iron Deficiency ◽  
Developmental Delay ◽  
Autism Spectrum ◽  
Spectrum Disorder ◽  
Global Developmental Delay

A homozygous missense mutation inHERC2associated with global developmental delay and autism spectrum disorder

2012 ◽  
Vol 33 (12) ◽  
pp. 1639-1646 ◽  
Author(s):  
Erik G. Puffenberger ◽  
Robert N. Jinks ◽  
Heng Wang ◽  
Baozhong Xin ◽  
Christopher Fiorentini ◽  
...  
Keyword(s):  
Autism Spectrum Disorder ◽  
Missense Mutation ◽  
Developmental Delay ◽  
Autism Spectrum ◽  
Spectrum Disorder ◽  
Global Developmental Delay ◽  
Homozygous Missense Mutation

scholarly journals A de novo TOP2B variant associated with global developmental delay and autism spectrum disorder

2020 ◽  
Vol 8 (3) ◽  
Author(s):  
Takuya Hiraide ◽  
Seiji Watanabe ◽  
Tomoko Matsubayashi ◽  
Kumiko Yanagi ◽  
Mitsuko Nakashima ◽  
...  
Keyword(s):  
Autism Spectrum Disorder ◽  
Developmental Delay ◽  
De Novo ◽  
Autism Spectrum ◽  
Spectrum Disorder ◽  
Global Developmental Delay

OP312 Developing A Tool-kit For Assessment Of Autism Spectrum Disorder

2021 ◽  
Vol 37 (S1) ◽  
pp. 12-12
Author(s):  
Leah Watson ◽  
Shirley Jonathan
Keyword(s):  
Autism Spectrum Disorder ◽  
Language Disorder ◽  
Autism Spectrum ◽  
Early Years ◽  
Spectrum Disorder ◽  
Global Developmental Delay ◽  
Evidence Based ◽  
Speech And Language ◽  
Autism Symptoms ◽  
Therapy Assessment

IntroductionBefore the coronavirus pandemic, children who were on the Early Years Neurodevelopment (EYND) assessment pathway and suspected to have possible Autism Spectrum Disorder (ASD), received clinic based appointments. This process included a parental interview by a doctor, a specialist speech and language therapy assessment, autism diagnostic observation schedule (ADOS), which were all carried out on hospital sites. These were postponed in March following national guidance. Our aim was to continue providing accurate evidence-based service for ASD diagnosis.MethodsWe utilised evidence-based telehealth methods to perform a specialist speech and language assessment in a child's home via video call. Parents were also invited to share videos of everyday activities via a secure portal. We could observe the child in a meaningful setting and witness functional impact of their needs. Each case is discussed by a multiagency panel based on DSM-V criteria.Online training was undertaken by professionals to deliver the Brief Observation of Autism Symptoms (BOSA) based on the ADOS for COVID times. Parents were coached by the therapist to enable them to become the administrator, rather than a professional.ResultsTelephonic feedback from the first ten parents whose children underwent a telehealth assessment has been positive; the home was deemed more natural and for some less distressing than clinic. Formal patient surveys have been devised for both the telehealth and BOSA clinic assessments. Analysis is expected by the end of March.To date we have been able to reach an outcome for thirty children, the diagnosis of ASD for twenty-four children and the other six received a diagnosis of global developmental delay or language disorder.ConclusionsWe expect that telehealth will reduce the number of assessments before an ASD diagnosis is made resulting in more prudent healthcare. The new methods have demonstrated clear increased parental participation.

Sign in / Sign up

Export Citation Format

Share Document